HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate Boosts Ad Spending Again After Organic Growth Falls Short

This article was originally published in The Pink Sheet & The Rose Sheet

Executive Summary

Colgate CEO Ian Cook expects brand investments will help boost organic sales 3%-5% in 2018. However, the firm's 24% increase in advertising and price cuts intended to spur product purchases failed to push sales to targets in the fourth quarter.

You may also be interested in...



Colgate Boosts Digital Marketing 20% To Engage With Consumers

Colgate targets at least 20% of its global media spending digitally as part of a larger marketing push to help counter marketplace uncertainties. It also is engaging in programs that create “meaning” for its brands and is engaging with consumers more on social media, says President and CEO Ian Cook.

Colgate Boosts Digital Marketing Spend In 2012

Colgate-Palmolive will boost digital media spend in 2012, with 13% of total ad dollars dedicated to the medium. Firm has 45 Facebook pages for its brands and is forming partnerships with Yahoo!, Microsoft and Amazon.com

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS122568

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel